Respiratory syncytial virus infections throughout life

Symposium
Chairs: M. Proesmans (Leuven, Belgium), S. Cunningham (Edinburgh (Scotland), United Kingdom)
Aims: to provide an update on the impact and epidemiology of respiratory syncytial virus (RSV) infections throughout life, including in the developing world; to provide an update and describe new results of ongoing trials of RSV antiviral treatment in children and adults; and to provide an update and describe new results of ongoing trials of RSV vaccination in pregnancy, infancy and old age.
Burden of RSV across all ages and continents
H. Nair (Edinburgh (Edinburgh), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
RSV disease in adults
P. Openshaw (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Development of RSV vaccines: where are we?
N. Scheltema (Utrecht, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
Development of RSV antiviral treatment: where are we?
S. Cunningham (Edinburgh (Scotland), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation